Literature DB >> 23036270

Impact of molecular diagnosis on treating Mendelian susceptibility to mycobacterial diseases.

Li-Hui Wang1, Chia-Liang Yen, Tsung-Chain Chang, Ching-Chuan Liu, Chi-Chang Shieh.   

Abstract

BACKGROUND/
OBJECTIVE: The IL-12-IFN-γ axis is critical for immune defense against mycobacterial infections. Inherited mutations that affect normal activation of this self-amplifying cytokine reaction lead to increased chances of mycobacterial infections, known as Mendelian susceptibility to mycobacterial diseases (MSMD). Delayed diagnosis and difficulty in identifying pathogenic mycobacteria hinder proper treatment of patients, so the aim of this study was to facilitate the diagnosis of mycobacterial infections in MSMD patients using an oligonucleotide array method.
METHODS: Peripheral blood mononuclear cells (PBMCs) were isolated from three MSMD patients in the same family. A series of immunologic studies, including testing for cytokine secretion after leukocyte stimulation, cell-surface marker analysis, and cDNA sequencing, were then performed. An oligonucleotide array was used to rapidly identify pathogens.
RESULTS: Cytokine secretion testing showed normal IFN-γ secretion after IL-12 stimulation but low IL-12 secretion after IFN-γ stimulation, which indicates a defect in the IFN-γ receptor or its intracellular signaling. Cell-surface receptor analysis showed IFN-γ receptor 1 overexpression, suggesting an autosomal dominant IFN-γ receptor 1 deficiency. cDNA sequencing identified the IFNGR1 818del4 mutation in three members of the family with known MSMD, and an oligonucleotide array identified Mycobacterium tuberculosis complex and Mycobacterium abscessus as pathogens.
CONCLUSIONS: Patients with suspected MSMD should undergo molecular diagnosis of the primary immunodeficiency. Oligonucleotide array methods may be a tool for rapid identification of pathogens and for guiding antimicrobial treatment in immunodeficient patients.
Copyright © 2012. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23036270     DOI: 10.1016/j.jmii.2012.08.017

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  5 in total

Review 1.  Clinical immunology and multiplex biomarkers of human tuberculosis.

Authors:  Gerhard Walzl; Mariëlle C Haks; Simone A Joosten; Léanie Kleynhans; Katharina Ronacher; Tom H M Ottenhoff
Journal:  Cold Spring Harb Perspect Med       Date:  2014-12-04       Impact factor: 6.915

2.  The South Asian genome.

Authors:  John C Chambers; James Abbott; Weihua Zhang; Ernest Turro; William R Scott; Sian-Tsung Tan; Uzma Afzal; Saima Afaq; Marie Loh; Benjamin Lehne; Paul O'Reilly; Kyle J Gaulton; Richard D Pearson; Xinzhong Li; Anita Lavery; Jana Vandrovcova; Mark N Wass; Kathryn Miller; Joban Sehmi; Laticia Oozageer; Ishminder K Kooner; Abtehale Al-Hussaini; Rebecca Mills; Jagvir Grewal; Vasileios Panoulas; Alexandra M Lewin; Korrinne Northwood; Gurpreet S Wander; Frank Geoghegan; Yingrui Li; Jun Wang; Timothy J Aitman; Mark I McCarthy; James Scott; Sarah Butcher; Paul Elliott; Jaspal S Kooner
Journal:  PLoS One       Date:  2014-08-12       Impact factor: 3.240

3.  Adverse Events of the BCG (Bacillus Calmette-Guérin) and Rotavirus Vaccines in a Young Infant with Inborn Error of Immunity.

Authors:  Suleiman Al-Hammadi; Najla S Alkuwaiti; Ghassan A Ghatasheh; Huda Al Dhanhani; Hiba M Shendi; Abdulghani S Elomami; Farida Almarzooqi; Abdul-Kader Souid
Journal:  Case Reports Immunol       Date:  2020-11-28

4.  Phenotypic and immune functional profiling of patients with suspected Mendelian Susceptibility to Mycobacterial Disease in South Africa.

Authors:  Ansia van Coller; Brigitte Glanzmann; Helena Cornelissen; Marlo Möller; Craig Kinnear; Monika Esser; Richard Glashoff
Journal:  BMC Immunol       Date:  2021-09-13       Impact factor: 3.615

5.  Case Report: BCG-Triggered Hemophagocytic Lymphohistiocytosis in an Infant With X-Linked Recessive Mendelian Susceptibility to Mycobacterial Disease Due to a Variant of Chronic Granulomatous Disease.

Authors:  Suleiman Al-Hammadi; Amal M Yahya; Abdulla Al-Amri; Amar Shibli; Ghazala B Balhaj; Mohamed I Tawil; Ranjit Vijayan; Abdul-Kader Souid
Journal:  Front Pediatr       Date:  2021-06-29       Impact factor: 3.418

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.